- Home
- -
Management
![](https://kemri-wellcome.org/zp-content/uploads/avatars/25/1659321116-bpfull.jpg)
Prof. Sam Muchina Kinyanjui 9
Director - IDeAL & Head Of Training
Biography
Sam started his research career in 1994 at the Wellcome Trust Labs in Nairobi doing malaria pharmacology studies and subsequently moved to Kilifi to study immunity to malaria as part of his PhD. In 2004, Sam was awarded a Wellcome Trust training fellowship. During the fellowship Sam also developed interest for capacity building for research and eventually in 2008 took up a post as the Head of Training and Capacity Building at the Programme. Sam’s roles include administering training activities and developing strategies for capacity building at the Programme and within the East African region as head of training at the KEMRI-Wellcome Trust Research Programme in Kenya.
Biography
Sam started his research career in 1994 at the Wellcome Trust Labs in Nairobi doing malaria pharmacology studies and subsequently moved to Kilifi to study immunity to malaria as part of his PhD. In 2004, Sam was awarded a Wellcome Trust training fellowship. During the fellowship Sam also developed interest for capacity building for research and eventually in 2008 took up a post as the Head of Training and Capacity Building at the Programme. Sam’s roles include administering training activities and developing strategies for capacity building at the Programme and within the East African region as head of training at the KEMRI-Wellcome Trust Research Programme in Kenya.
Current Work
Collaborations
Project Research
No active details yet
Videos
Publications
A scoping review of ethics review processes during public health emergencies in Africa.
Orievulu, K., Hinga, A., Nkosi, B., Ngwenya, N., Seeley, J., Akanlu, A., Tindana, P., Molyneux, S., Kinyanjui, S., Kamuya, D.
BMC Med Ethics, (2024). 25:63
Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against Plasmodium falciparum parasites.
Ogwang, R., Murugu, L., Nkumama, I. N., Nyamako, L., Kai, O., Mwai, K., Murungi, L., Idro, R., Bejon, P., Tuju, J., Kinyanjui, S. M., Osier, F. H. A.
Front Immunol, (2024). 15:1360220
Designing and delivering bioinformatics project-based learning in East Africa.
Kibet, C. K., Entfellner, J. D., Jjingo, D., de Villiers, E. P., de Villiers, S., Wambui, K., Kinyanjui, S., Masiga, D.
BMC Bioinformatics, (2024). 25:150
Antibody-Dependent Respiratory Burst against Plasmodium falciparum Merozoites in Individuals Living in an Area with Declining Malaria Transmission.
Mutemi, D. D., Tuju, J., Ogwang, R., Nyamako, L., Wambui, K. M., Cruz, I. R., Villner, P., Yman, V., Kinyanjui, S. M., Rooth, I., Ngasala, B., Färnert, A., Osier, F. H. A.
Vaccines (Basel), (2024). 12:
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Odera, D. O., Tuju, J., Mwai, K., Nkumama, I. N., Fürle, K., Chege, T., Kimathi, R., Diehl, S., Musasia, F. K., Rosenkranz, M., Njuguna, P., Hamaluba, M., Kapulu, M. C., Frank, R., Osier, F. H. A., Abdi, A. I., Chi, P. C., de Laurent, Z., Jao, I., Kamuya, D., Kamuyu, G., Makale, J., Murungi, L., Musyoki, J., Muthui, M., Mwacharo, J., Kariuki, S., Mwanga, D., Mwongeli, J., Ndungu, F., Njue, M., Nyangweso, G., Kimani, D., Ngoi, J. M., Musembi, J., Ngoto, O., Otieno, E., Ooko, M., Shangala, J., Wambua, J., Mohammed, K. S., Omuoyo, D., Mosobo, M., Kibinge, N., Kinyanjui, S., Bejon, P., Lowe, B., Marsh, K., Marsh, V., Abebe, Y., Billingsley, P. F., Sim, B. K. L., Hoffman, S. L., James, E. R., Richie, T. L., Audi, A., Olewe, F., Oloo, J., Ongecha, J., Ongas, M. O., Koskei, N., Bull, P. C., Hodgson, S. H., Kivisi, C., Imwong, M., Murphy, S. C., Ogutu, B., Tarning, J., Winterberg, M., Williams, T. N.
Sci Transl Med, (2023). 15:eabn5993